IPHS Insider Trading Activity and SEC Form 4 Filings
IPHS insider trading summary
No open-market insider purchases or sales of Innophos Holdings, Inc. (IPHS) have been reported on SEC Form 4 in the past 12 months.
Latest IPHS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 13, 2019 | John M Steitz | Director | Sell | $402K (12,625 @ $31.86) |
| Mar 3, 2017 | Charles Brodheim | VP, Corporate Controller | Sell | $594K (11,000 @ $54.00) |
| Mar 3, 2017 | Charles Brodheim | VP, Corporate Controller | Sell | $82K (1,523 @ $54.02) |
| Sep 9, 2016 | Robert J Zatta | Director | Buy | $40K (1,000 @ $40.31) |
| Jun 22, 2016 | Joseph Golowski | VP-Specialty Ingredients | Sell | $202K (5,000 @ $40.46) |
| May 24, 2016 | Robert J Zatta | Director | Buy | $37K (1,000 @ $37.11) |
| Mar 11, 2016 | Robert J Zatta | Director | Buy | $57K (2,000 @ $28.27) |
| Feb 25, 2016 | John M Steitz | Director | Buy | $270K (10,000 @ $26.95) |
| Apr 15, 2015 | Randy Gress | CEO | Sell | $1.2M (20,000 @ $58.68) |
| Mar 20, 2015 | Louis Calvarin | VP-Corp Strategy & CRO | Sell | $570K (10,000 @ $57.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.